Besides, it is also demonstrated that the dual-targeting PI3K and HDAC inhibitor BEBT-908 can promote ferroptosis of cancer cells by hyperacetylating p53 and promoting the expression of ferroptotic signaling (Liu et al., 2019; Fan et al., 2021). Here, TP53 is linked to cancer.